Document Detail

Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.
MedLine Citation:
PMID:  20371240     Owner:  NLM     Status:  MEDLINE    
Metabotropic glutamate receptors (mGlu receptors), with their unique signaling systems and pharmacological characteristics, have emerged as a new topic in excitatory amino acid research. Among them, the unique distribution of group II mGlu receptors, such as mGlu(2) and mGlu(3) receptors, and the involvement of these receptors in the regulation of neurotransmission are particularly interesting. Recently, potent agonists for mGlu(2/3) receptor have been synthesized, and their pharmacological roles have been intensively investigated using animal models. mGlu(2/3) receptors clearly have crucial roles in the central nervous system, and accumulating evidence in both rodents and human studies has suggested that agonists for mGlu(2/3) receptors may be beneficial for the treatment of psychiatric disorders such as schizophrenia. Possible neuronal circuits through which mGlu(2/3) receptor agonists exert their pharmacological effects have also been investigated.
Shigeyuki Chaki
Publication Detail:
Type:  Journal Article; Review     Date:  2010-04-02
Journal Detail:
Title:  European journal of pharmacology     Volume:  639     ISSN:  1879-0712     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-06-23     Completed Date:  2010-11-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  59-66     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier B.V. All rights reserved.
Discovery Pharmacology, Molecular Function and Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antipsychotic Agents / chemical synthesis,  chemistry,  pharmacology,  therapeutic use*
Excitatory Amino Acid Agonists / chemical synthesis,  chemistry,  pharmacology,  therapeutic use*
Receptors, Metabotropic Glutamate / agonists*,  chemistry,  metabolism
Schizophrenia / drug therapy*
Synaptic Transmission / drug effects,  physiology
Reg. No./Substance:
0/Antipsychotic Agents; 0/Excitatory Amino Acid Agonists; 0/Receptors, Metabotropic Glutamate; 0/metabotropic glutamate receptor 2; 0/metabotropic glutamate receptor 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A study on inhibition Mechanism of breast cancer cells by bis-type triaziquone.
Next Document:  Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by an metabotropic glu...